Vertex Pharmaceuticals Inc
VRTX
NASDAQ
Biotechnology
$505.75
USD
-10.69 (-2.07%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $135.24B
Volume 1.1M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
AMGN | Amgen Inc | $225.00B | 25.73 | +9.1% | +2.3% | |
GILD | Gilead Sciences, Inc | $169.87B | - | +5.5% | +3.6% | |
VRTX | Vertex Pharmaceuticals Inc | $135.24B | 30.70 | +10.2% | - | |
REGN | Regeneron Pharmaceuticals Inc | $82.16B | 18.98 | +9.3% | +0.5% | |
NTRA | Natera Inc | $44.64B | - | +37.8% | - | |
RVMD | Revolution Medicines Inc | $44.51B | - | - | - | |
BIIB | Biogen Inc | $31.05B | 37.20 | +0.3% | - | |
ALNY | Alnylam Pharmaceuticals Inc | $29.97B | 37.09 | +95.1% | - |
Top Peer by Growth
Alnylam Pharmaceuticals Inc
+95.1% YoY Revenue
Lowest P/E Ratio
Regeneron Pharmaceuticals Inc
18.98x P/E
Best 1-Year Return
Revolution Medicines Inc
+460.0% Return